Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 4/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.42 |
| ▸ | PTPRB | P23467 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.42 |
| ▸ | CSK | P41240 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27477965 | 1.00 | ALDH1A1 (0.51) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| SCHEMBL5916451 | 1.00 | ALDH1A1 (0.51) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| Hydrochloric Acid SCHEMBL7387839 | 0.98 | ALDH1A1 (0.53) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| Hydrochloric Acid SCHEMBL7385556 | 0.98 | ALDH1A1 (0.53) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| Hydrochloric Acid SCHEMBL3871196 | 0.98 | ALDH1A1 (0.53) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| SCHEMBL4087293 | 0.92 | PTGS2 (0.50) | ALDH1A1ESR1ESR2PTGS2LTA4H | |
| SCHEMBL24648907 | 0.86 | ESR1 (0.51) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| SCHEMBL22444654 | 0.86 | ESR1 (0.51) | ALDH1A1ESR1ESR2SLC7A5PTGS2 | |
| Tyrosine Methyl Ester SCHEMBL314923 | 0.86 | ESR1 (0.63) | ALDH1A1ESR1ESR2SLC7A5LNPEP | |
| SCHEMBL12028471 | 0.86 | ALDH1A1 (0.51) | ALDH1A1ESR1ESR2SLC7A5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116655543-A | Preparation method of ulcerative colitis treatment medicine | 北京康立生医药技术开发有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-114907546-B | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2023-06-02 | — | — | CN | claimed |
| CN-114907546-A | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2022-08-16 | — | — | CN | claimed |
| CN-114716635-A | Multifunctional polyurea-amino acid derivative and preparation method and application thereof | 四川大学 | 2022-07-08 | — | — | CN | claimed |
| EP-4289483-A2 | BIOMOLECULE CONJUGATES | Celgene Corporation (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-116655543-A | Preparation method of ulcerative colitis treatment medicine | 北京康立生医药技术开发有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-114907546-B | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-114907546-A | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2022-08-16 | — | — | CN | disclosed |
| CN-114716635-A | Multifunctional polyurea-amino acid derivative and preparation method and application thereof | 四川大学 | 2022-07-08 | — | — | CN | disclosed |
| EP-3903826-A1 | BIOMOLECULE CONJUGATES | Celgene Corporation (US) | 2021-11-03 | — | — | EP | disclosed |
| CN-104185477-B | Cytotoxic peptides and antibody-drug conjugates thereof | 辉瑞公司 | 2017-05-24 | — | — | CN | disclosed |
| US-9138486-B2 | Cytotoxic peptides and antibody drug conjugates thereof | PFIZER INC. (US) | 2015-09-22 | — | — | US | disclosed |
| EP-0891325-B1 | PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | SEARLE & CO (US) | 2002-02-06 | — | — | EP | disclosed |
| EP-1157985-A1 | Para- substituted phenylene derivatives and their use as integrin antagonists | G.D. SEARLE & CO. (US) | 2001-11-28 | — | — | EP | disclosed |
| US-6251944-B1 | (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY | G. D. SEARLE & COMPANY | 2001-06-26 | — | — | US | disclosed |
| US-5952381-A | SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS | G. D. SEARLE & CO. (US) | 1999-09-14 | — | — | US | disclosed |
| US-5412145-A | P2'-modified hydroxamic acid collagenase inhibitors | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1995-05-02 | — | — | US | disclosed |
| US-5300674-A | P2'-modified hydroxamic acid collagenase inhibitors | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1994-04-05 | — | — | US | disclosed |
| WO-1992013831-A1 | HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1992-08-20 | — | — | WO | disclosed |
| EP-0498665-A1 | Hydroxamic acids derivatives, process for their preparation and use thereof | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1992-08-12 | — | — | EP | disclosed |